Thomas Meier

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2011-04-21

Top Assignees for applications by Thomas Meier

The entities that hold a legal rights for patent applications filed by inventor Meier Thomas:

SANTHERA PHARMACEUTICALS (SCHWEIZ) AG 5 Liestal, Switzerland
The USA, as represented by the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH 1 Liestal, Switzerland
SANTHERA PHARMACEUTICALS (SCHWEIZ) AG 1 Liestal Switzerland, Switzerland
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States

Recent patent applications by Meier Thomas

Thomas Meier from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-04-21

US20110092469A1

Human necessities

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy

#2 | 2010-11-04

US20100280130A1

Human necessities

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

#3 | 2010-06-24

US20100160269A1

Human necessities

Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy

#4 | 2009-07-09

US20090176867A1

Human necessities

N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency

#5 | 2009-01-08